1313498-08-6

Basic information

• Product Name: LSN2814617
• Synonyms: LSN2814617;LSN2814617 racemate;3-(1,1-Dimethylethyl)-7-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridine;1,2,4-Triazolo[4,3-a]pyridine, 3-(1,1-dimethylethy
• CAS NO: 1313498-08-6
• Molecular Formula: C₁₈H₂₀FN₅O
• Molecular Weight: 341.38
• EINECS: -0
• Mol File: 1313498-08-6.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: LSN2814617(CAS DataBase Reference)
• NIST Chemistry Reference: LSN2814617(1313498-08-6)
• EPA Substance Registry System: LSN2814617(1313498-08-6)

Safety Data

• Hazardous Substances Data: 1313498-08-6(Hazardous Substances Data)

Usage

General Description

LSN2814617 is a chemical compound that acts as a potent and selective antagonist at the histamine H3 receptor. It has been studied for its potential use in the treatment of various neurological and psychiatric disorders, including attention deficit hyperactivity disorder (ADHD), Alzheimer's disease, and schizophrenia. LSN2814617 has been shown to improve cognitive function and memory in preclinical studies, making it a promising candidate for the development of novel therapeutics targeting the histamine H3 receptor. Additionally, LSN2814617 has also been investigated for its potential use as a tool compound in research to further understand the role of histamine H3 receptor in various physiological and pathological processes in the brain.

Upstream product

• 142851-03-4 1-tert-butyl 4-ethyl piperidine-1,4-dicarboxylate 
• 1313498-24-6 methyl 2-methylthio-3,4,5,6-tetrahydropyridine-4-carboxylate trifluoromethanesulfonic acid 
• 1313498-22-4 methyl 2-thioxopiperidine-4-carboxylate 
• 1313498-27-9 2-methoxy-3,4,5,6-tetrahydropyridine-4-carboxylic acid ethyl ester 
• 1313498-26-8 1-tert-butyl 4-ethyl 2-oxopiperidine-1,4-dicarboxylate 
• 25504-47-6 methyl (RS)-2-oxopiperidine-4-carboxylate 
• 1313498-28-0 ethyl 3-tert-butyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine-7-carboxylate 
• 22179-78-8 4-fluoro-benzamidoxime 
• 1313498-25-7 methyl 3-tert-butyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine-7-carboxylate 
• 25410-09-7 ethyl 2-oxopiperidine-4-carboxylate 

Downstream Products

• 1313498-17-7 LS⁽¹⁴⁶⁾N₂₈₁₇ 

Relevant articles and documents

TETRAHYDROTRIAZOLOPYRIDINE COMPOUNDS AS SELECTIVE MGLU5 RECEPTOR POTENTIATORS USEFUL FOR THE TREATMENT OF SCHIZOPHRENIA

The present invention provides certain tetrahydrotriazolopyridine derivatives, pharmaceutical compositions thereof, methods of using the same and processes for preparing the same. Formula (I) wherein R1 is hydrogen, fluoro, chloro, or methyl; and R2 is C4 - CS branched alkyl.